Use of the ALDEFLUOR approach (by flow cytometry) and/or the detection of ALDH1-positive cells at the cytoplasmic level by immunohistochemistry identified highly tumorigenic cells not only within breast cancer specimens but also in brain tumors, leukemia and multiple myeloma. Here, ALDH1A1 is linked to breast cancer.